ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 247 filers reported holding ICU MED INC in Q4 2022. The put-call ratio across all filers is 4.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,785 | +100.3% | 15 | +200.0% | 0.00% | – |
| Q2 2023 | $891 | +8.0% | 5 | 0.0% | 0.00% | – |
| Q1 2023 | $825 | +4.8% | 5 | 0.0% | 0.00% | – |
| Q4 2022 | $787 | -91.3% | 5 | -91.5% | 0.00% | – |
| Q3 2022 | $9,000 | +125.0% | 59 | +156.5% | 0.00% | – |
| Q2 2022 | $4,000 | -87.9% | 23 | -84.2% | 0.00% | -100.0% |
| Q1 2022 | $33,000 | -5.7% | 146 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | +29.6% | 146 | +27.0% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | +107.7% | 115 | +79.7% | 0.00% | 0.0% |
| Q2 2021 | $13,000 | -13.3% | 64 | -13.5% | 0.00% | 0.0% |
| Q1 2021 | $15,000 | -11.8% | 74 | -5.1% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | +6.2% | 78 | -8.2% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | +128.6% | 85 | +123.7% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 38 | +35.7% | 0.00% | – |
| Q1 2020 | $5,000 | -68.8% | 28 | -67.8% | 0.00% | -100.0% |
| Q4 2019 | $16,000 | +1500.0% | 87 | +1640.0% | 0.00% | – |
| Q3 2019 | $1,000 | -98.1% | 5 | -98.6% | 0.00% | -100.0% |
| Q4 2016 | $52,000 | – | 352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |